News – Page 1128 – Endpoints News

Retrophin takes the ax to its Cambridge office as it concentrates on late-stage R&D push

9 years ago

Merck KGaA in talks to sell its biosimilars R&D ops as shakeout looms

9 years ago

Cummings: Trump offers a high-five on Medicare drug price negotiations, a federal formulary and imports

9 years ago

Under the gun after Opdivo setbacks, Bristol-Myers Squibb names a new chief scientist

9 years ago

Global Blood Therapeutics shares spike on buzz about a potential Novo buyout

9 years ago

Soon-Shiong blasts back at “maliciously false” STAT story; ImmunoMet raises $5M

9 years ago

Google’s venture arm leads Spero’s $51.7M round for R&D work on a pipeline of new antibiotics

9 years ago

Intellia fine tunes its CRISPR/Cas9 tech ahead of human studies

9 years ago

Do big R&D budgets justify US premium drug prices? No way, analysts scoff

9 years ago

High-profile biotech leader Deborah Dunsire takes the helm at XTuit, focused on cancer and fibrosis

9 years ago

Biotech spinout grabs $46M round, jumps straight into PhIII with a drug/device combo for rare lung condition

9 years ago

Trump tweets a new vow to spur competition in the pharma biz, slashing prices

9 years ago

Soon-Shiong’s NantHealth tanks on STAT report of self-dealing; Bioversys, Aptuit forge antibiotic collab; Helix ...

9 years ago

Merck, Pfizer line up a big FDA decision on a blockbuster hopeful, staring down some major league competition

9 years ago

With a big cash assist from local officials, BeiGene is building a $330M biologics facility in China

9 years ago

Roche is bringing back gantenerumab from the dead, taking another stab at Alzheimer’s PhIII

9 years ago

FDA lifts its hold on vadastuximab talirine after Seattle Genetics adds new safeguards

9 years ago

Snubbed at the FDA, PTC files their three-time loser for Duchenne MD over protest

9 years ago

GSK vet named CEO of China CAR-T JV with Kite; Coherus fights back against Amgen claims it stole trade secrets

9 years ago

TG Therapeutics shares rocket up on successful PhIII leukemia study, teeing up a shot at accelerated FDA OK

9 years ago

Ionis rolls out promising PhIII data on volanesorsen for rare enzyme disorder, but safety questions linger

9 years ago

Defending its prize franchise, Vertex forks over $160M cash to grab Concert’s simplified version of Kalydeco

9 years ago

Otsuka Pharma snags a late-stage ADHD drug in $250M Neurovance buyout

9 years ago

Regeneron, Sanofi, get ready to duke it out with Pfizer over a megablockbuster eczema market

9 years ago

First page Previous page 1125 1126 112711281129 1130 1131 Next page Last page